Aurora Cannabis Q3 2023 Earnings Supplemental Report

Aurora Cannabis reported Adjusted EBITDA profitability for two consecutive quarters through March 2023, achieving ~$400 million in annualized cost savings since 2020. The company maintains its position as Canada's #1 LP in global medical cannabis revenues with approximately $230 million in cash and focus on positive free cash flow generation.